Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration

蔡嘉仁、陳榮福（2013）。Pharmacological Interventions on Osteoporosis。台灣醫學，17(5)，510-516。https://doi.org/10.6320/FJM.2013.17(5).07
Chen, J. L., Chang, F. C., Lee, C. Y., Huang, T. W., Huang, K. C., & Lee, M. S. (2017). Effects of anti-osteoporosis medications on osteoporotic hip fractures. Formosan Journal of Musculoskeletal Disorders, 8(4), 154-160. https://doi.org/10.6492/FJMD.20161014
陳東明（2006）。Impacting Factors of Osteoporosis〔碩士論文，亞洲大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0118-0807200916274283
Shih, C., Peng, T. K., & Lin, T. W. (2003). Systemic Osteoporosis and Mandibular Bone Quality. 中華民國口腔植體學會會訊, (38&39&40), 29-33. https://doi.org/10.30013/CHMKKCCTHHHH.200306.0005
Sarkar, M., Bhardwaj, R., Madabhavi, I., & Khatana, J. (2015). Osteoporosis in Chronic Obstructive Pulmonary Disease. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, (2015), 5-21. https://doi.org/10.4137/CCRPM.S22803